Modeling the impact of different PrEP targeting strategies combined with a clinic-based HIV-1 nucleic acid testing intervention in Kenya

Background: Up to 69% of adults who acquire HIV in Kenya seek care for acute retroviral symptoms, providing an important opportunity for early diagnosis and HIV care engagement. The Tambua Mapema Plus (TMP) trial tested a combined HIV-1 nucleic acid testing, linkage, treatment, and partner notificat...

Full description

Bibliographic Details
Main Authors: Deven T. Hamilton, Clara Agutu, Martin Sirengo, Wairimu Chege, Steven M. Goodreau, Adam Elder, Eduard J. Sanders, Susan M. Graham
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Epidemics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1755436523000324